References
- Antushevich, H. and Wójcik, M., 2018. Review: apelin in disease. Clinica chimica acta, 483, 241–248.
- Bozaoglu, K., et al., 2010. Chemerin, a novel adipokine in the regulation of angiogenesis. The journal of clinical endocrinology and metabolism, 95(5), 2476–2485.
- Castan-Laurell, I., et al., 2011. Apelin, diabetes, and obesity. Endocrine, 40(1), 1–9.
- Castan-Laurell, I., et al., 2012. Apelin, a promising target for type 2 diabetes treatment? Trends in endocrinology and metabolism, 23(5), 234–241.
- Cheng, J., et al., 2019. Apelin/APJ system: a potential therapeutic target for endothelial dysfunction-related diseases. Journal of cellular physiology, 234(8), 12149–12160.
- Döcke, S., et al., 2013. Elevated hepatic chemerin mRNA expression in human non-alcoholic fatty liver disease. European journal of endocrinology, 169(5), 547–557.
- Du, J., et al., 2016. Increased serum chemerin levels in diabetic retinopathy of type 2 diabetic patients. Current eye research, 41(1), 114–120.
- Du, J.-H., et al., 2014. Elevation of serum apelin-13 associated with proliferative diabetic retinopathy in type 2 diabetic patients. International journal of ophthalmology, 7(6), 968–973.
- Fasshauer, M. and Blüher, M., 2015. Adipokines in health and disease. Trends in pharmacological sciences, 36(7), 461–470.
- Fitzgerald, S.J., et al., 2018. A new approach to study the sex differences in adipose tissue. Journal of biomedical science, 25(1), 89.
- Gadkari, S.S., Maskati, Q.B., and Nayak, B.K., 2016. Prevalence of diabetic retinopathy in India: the All India Ophthalmological Society Diabetic Retinopathy Eye Screening Study 2014. Indian journal of ophthalmology, 64(1), 38–44.
- Gomes, B.F. and Accardo, C. M., 2019. Immunoinflammatory mediators in the pathogenesis of diabetes mellitus. Einstein (Sao Paulo, Brazil), 17(1), eRB4596.
- Greulich, S., et al., 2013. Cardioprotective properties of omentin-1 in type 2 diabetes: evidence from clinical and in vitro studies. PLoS one, 8(3), e59697.
- Gu, P., et al., 2019. Increased circulating chemerin in relation to chronic microvascular complications in patients with type 2 diabetes. International journal of endocrinology, 2019, 1.
- Guzel, E.C., et al., 2014. Omentin and chemerin and their association with obesity in women with polycystic ovary syndrome. Gynecological endocrinology, 30(6), 419–422.
- Kasai, A., et al., 2013. Inhibition of apelin expression switches endothelial cells from proliferative to mature state in pathological retinal angiogenesis. Angiogenesis, 16(3), 723–734.
- Kaur, J., et al., 2010. Identification of chemerin receptor (ChemR23) in human endothelial cells: chemerin-induced endothelial angiogenesis. Biochemical and biophysical research communications, 391(4), 1762–1768.
- Kazama, K., et al., 2012. Omentin plays an anti-inflammatory role through inhibition of TNF-α-induced superoxide production in vascular smooth muscle cells. European journal of pharmacology, 686(1–3), 116–123.
- Korany, M.A., Sonbol, A., and Elgouhary, S.M., 2018. Omentin-1 and diabetic retinopathy in type 2 diabetic patients. Alexandria journal of medicine, 54(4), 323–326.
- Lee, E.Y., et al., 2016. Triglyceride glucose index, a marker of insulin resistance, is associated with coronary artery stenosis in asymptomatic subjects with type 2 diabetes. Lipids in health and disease, 15(1), 155.
- Liu, H., et al., 2015. Association of serum omentin-1 concentrations with the presence and severity of preeclampsia. Annals of clinical biochemistry, 52(2), 245–250.
- Liu, Y., et al., 2017. Risk factors of diabetic retinopathy and sight-threatening diabetic retinopathy: a cross-sectional study of 13 473 patients with type 2 diabetes mellitus in mainland China. BMJ open, 7(9), e016280.
- Lum, F., et al., 2016. The Preferred Practice Pattern Guidelines in Ophthalmology. Ophthalmology, 123(5), 928–929.
- Mattern, A., Zellmann, T., and Beck-Sickinger, A.G., 2014. Processing, signaling, and physiological function of chemerin. IUBMB life, 66(1), 19–26.
- Matthews, D.R., et al., 1985. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28(7), 412–419.
- Ohashi, K., et al., 2014. Role of anti-inflammatory adipokines in obesity-related diseases. Trends in endocrinology & metabolism, 25(7), 348–355.
- Piya, M.K., McTernan, P.G., and Kumar, S., 2013. Adipokine inflammation and insulin resistance: the role of glucose, lipids and endotoxin. Journal of endocrinology, 216(1), T1–T15.
- Roman, A.A., Parlee, S.D., and Sinal, C.J., 2012. Chemerin: a potential endocrine link between obesity and type 2 diabetes. Endocrine, 42(2), 243–251.
- Sanchez-Rebordelo, E., et al., 2018. Regulation of chemerin and CMKLR1 expression by nutritional status, postnatal development, and gender. International journal of molecular sciences, 19(10), 2905.
- Scheja, L. and Heeren, J., 2019. The endocrine function of adipose tissues in health and cardiometabolic disease. Nature reviews endocrinology, 15(9), 507–524.
- Senthilkumar, G.P., et al., 2018. Role of omentin 1 and IL-6 in type 2 diabetes mellitus patients with diabetic nephropathy. Diabetes & metabolic syndrome: clinical research and reviews, 12 (1), 23–26.
- Simental-Mendía, L.E., Rodríguez-Morán, M., and Guerrero-Romero, F., 2008. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metabolic syndrome and related disorders, 6(4), 299–304.
- Smitka, K. and Marešová, D., 2015. Adipose tissue as an endocrine organ: an update on pro-inflammatory and anti-inflammatory microenvironment. Prague medical report, 116(2), 87–111.
- Sperling, M., et al., 2016. Concentrations of omentin and vaspin versus insulin resistance in obese individuals. Biomedicine and pharmacotherapy, 83, 542–547.
- Tan, B.K., et al., 2010. Metformin treatment may increase omentin-1 levels in women with polycystic ovary syndrome. Diabetes, 59(12), 3023–3031.
- Tangvarasittichai, S., 2015. Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus. World journal of diabetes, 6(3), 456–480.
- Thapa, R., et al., 2018. Prevalence and risk factors of diabetic retinopathy among an elderly population with diabetes in Nepal: the Bhaktapur Retina Study. Clinical ophthalmology, 12, 561–568.
- Treeck, O., Buechler, C., and Ortmann, O., 2019. Chemerin and Cancer. International journal of molecular sciences, 20(15), 3750.
- Vasques, A.C.J., et al., 2011. TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes research and clinical practice, 93(3), e98–e100.
- Wan, T.-T., et al., 2015. Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy. Biomedicine and pharmacotherapy = pharmacotherapy, 74, 145–147.
- Wan, W., et al., 2015. Serum and vitreous concentrations of omentin-1 in diabetic retinopathy. Disease markers, 2015, 1–4.
- Wang, Q., et al., 2013. Decreased levels of serum omentin-1 in patients with obstructive sleep apnoea syndrome. Annals of clinical biochemistry, 50(3), 230–235.
- Watanabe, T., et al., 2017. Adipose tissue-derived omentin-1 function and regulation. Comprehensive physiology, 7(3), 765–781.
- Wilkinson, C.P., et al., 2003. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology, 110(9), 1677–1682.
- Wu, L., Chen, L., and Li, L., 2017. Apelin/APJ system: a novel promising therapy target for pathological angiogenesis. Clinica chimica acta, 466, 78–84.
- Yang, R.-Z., et al., 2006. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. American journal of physiology-endocrinology and metabolism, 290(6), E1253–1261.
- Yau, J.W.Y., et al., 2012. Global prevalence and major risk factors of diabetic retinopathy. Diabetes care, 35(3), 556–564.
- Yue, P., et al., 2010. Apelin is necessary for the maintenance of insulin sensitivity. American journal of physiology-endocrinology and metabolism, 298(1), E59–67.
- Zhang, K., et al., 2017. The Triglycerides and Glucose Index rather than HOMA-IR is more associated with Hypogonadism in Chinese men. Scientific reports, 7(1), 15874.
- Zhong, X., et al., 2012. Omentin inhibits TNF-α-induced expression of adhesion molecules in endothelial cells via ERK/NF-κB pathway. Biochemical and biophysical research communications, 425(2), 401–406.